{"id":"W2054266161","doi":"10.1097/jto.0b013e3182370e02","title":"Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer: Safety of Avastin in Lung trial (MO19390)","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Bevacizumab; Internal medicine; Lung cancer; Adverse effect; Surgery; Clinical endpoint; Chemotherapy; Proteinuria; Oncology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009870746,0.0009412694,0.001947334,0.0002844103,0.0002940541,0.0008177142,0.0006546092,0.00104872,0.002008376],"category_scores_gemma":[0.001308498,0.000376669,0.00156227,0.0003286031,0.0005400018,0.0007744923,0.0003512564,0.002312635,0.0003993787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001169324,"about_ca_system_score_gemma":0.0008678293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001420263,"about_ca_topic_score_gemma":0.00412354,"domain_scores_codex":[0.9995845,0.000182704,0.00002509246,0.00009345199,0.00003935915,0.00007490511],"domain_scores_gemma":[0.9992943,0.0001291756,0.0001993811,0.00004517921,0.00004255214,0.0002893459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9121463,0.005369269,0.0183691,0.0003420732,0.002903672,0.0001307969,0.00008459497,0.001325787,0.01010431,0.0001216925,0.001920499,0.04718181],"study_design_scores_gemma":[0.6473199,0.2375816,0.1017195,0.000066737,0.003672526,0.0004250831,0.00008615604,0.002818222,0.003508522,0.0003723675,0.002364949,0.0000644547],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967709,0.001435478,0.0001044776,0.0002610811,0.00008070001,0.0001401977,0.0005838966,0.00002291761,0.000600289],"genre_scores_gemma":[0.9967387,0.0007004416,0.0002107622,0.0002858364,0.0001394425,0.0001481388,0.0009458984,0.00001110185,0.0008194988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002008376,"threshold_uncertainty_score":0.008484066,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01785785008203621,"score_gpt":0.3734871761368151,"score_spread":0.3556293260547789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}